Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anti-VEGF monotherapy vs combination with EPM laser for DME
NCT02462304Phase 4Unknown
- Sponsor
- The University of Hong Kong
- Start
- Jun 2015
- Primary completion
- Jun 2017
- Modality
- Antibody Fragments, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of ranibizumab, bevacizumab in diabetic macular edema (DME), sponsored by The University of Hong Kong. Status: unknown.
02
Drugs
ranibizumabbevacizumab
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT02462304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02462304.